ProMIS Neurosciences, Inc.
Price Action
Technical Summary
EMERGING TRENDProMIS Neurosciences, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 74), indicating performance broadly in line with the market. Earnings growth of 76% provides fundamental context to the price action. However, price is extended 27% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $11.15 | +23.09% | ABOVE |
| 50 SMA | $10.81 | +27.00% | ABOVE |
| 100 SMA | $13.58 | +1.10% | ABOVE |
| 150 SMA | $12.15 | +13.01% | ABOVE |
| 200 SMA | $11.79 | +16.49% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is PMN in an uptrend right now?
PMN has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is PMN overbought or oversold?
PMN's RSI (14) is 74. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is PMN outperforming the market?
PMN has a Relative Strength (RS) Rating of 74 out of 99. PMN is performing about average compared to the market.
Where is PMN in its 52-week range?
PMN is trading at $13.73, which is 35% of its 52-week high ($39.75) and 22% above its 52-week low ($6.27).
How volatile is PMN?
PMN has a Beta of 1.17 and 52-week volatility of 106%. It's more volatile than the S&P 500 - expect bigger swings.